How does Cryptococcus get its coat?

被引:55
作者
Doering, TL [1 ]
机构
[1] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
关键词
D O I
10.1016/S0966-842X(00)01890-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During the past few decades, increasing attention has focused on pathogenic fungi both as fascinating research subjects and as the agents of serious illness in diverse patient populations. In particular, opportunistic fungi such as Cryptococcus neoformans command notice as the ranks of their immunocompromised victims grow. C. neoformans is unique among fungal pathogens for its major virulence factor, a complex polysaccharide capsule. In this article, our current understanding of the structure and biosynthesis of the capsule is reviewed, as are the many questions that remain to be answered about how Cryptococcus gets its coat.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 75 条
[1]   Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP [J].
Alspaugh, JA ;
Perfect, JR ;
Heitman, J .
GENES & DEVELOPMENT, 1997, 11 (23) :3206-3217
[2]   BIOSYNTHESIS OF URIDINE DIPHOSPHATE D-XYLOSE .2. URIDINE DIPHOSPHATE D-GLUCURONATE CARBOXY-LYASE OF CRYPTOCOCCUS LAURENTII [J].
ANKEL, H ;
FEINGOLD, DS .
BIOCHEMISTRY, 1966, 5 (01) :182-&
[3]   BIOSYNTHESIS OF URIDINE DIPHOSPHATE D-XYLOSE .3. URIDINE DIPHOSPHATE D-GLUCOSE DEHYDROGENASE OF CRYPTOCOCCUS LAURENTII [J].
ANKEL, H ;
ANKEL, E ;
FEINGOLD, DS .
BIOCHEMISTRY, 1966, 5 (06) :1864-&
[4]   DETERMINATION OF ANTIGEN-BINDING SPECIFICITIES OF CRYPTOCOCCUS-NEOFORMANS FACTOR SERA BY ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
BELAY, T ;
CHERNIAK, R .
INFECTION AND IMMUNITY, 1995, 63 (05) :1810-1819
[5]  
BERGMAN F, 1965, SABOURAUDIA, V2, P23
[6]  
BLOOMFIELD N, 1963, P SOC EXP BIOL MED, V114, P64, DOI 10.3181/00379727-114-28586
[7]   What makes Cryptococcus neoformans a pathogen? [J].
Buchanan, KL ;
Murphy, JW .
EMERGING INFECTIOUS DISEASES, 1998, 4 (01) :71-83
[8]   Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies [J].
Casadevall, A ;
Cleare, W ;
Feldmesser, M ;
Glatman-Freedman, A ;
Goldman, DL ;
Kozel, TR ;
Lendvai, N ;
Mukherjee, J ;
Pirofski, LA ;
Rivera, J ;
Rosas, AL ;
Scharff, MD ;
Valadon, P ;
Westin, K ;
Zhong, ZJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) :1437-1446
[9]  
Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, DOI DOI 10.1128/9781555818241
[10]   Cryptococcus neoformans STE12α regulates virulence but is not essential for mating [J].
Chang, YC ;
Wickes, BL ;
Miller, GF ;
Penoyer, LA ;
Kwon-Chung, KJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) :871-881